$1.35 Billion is the total value of Novo Holdings A/S's 40 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 12.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | BROOKFIELD CORPcl a ltd vt sh | $121,334,792 | – | 3,880,230 | +100.0% | 8.97% | – | |
ASML | ASML HOLDING N V | $116,413,402 | -18.8% | 197,760 | 0.0% | 8.60% | -22.3% | |
CRM | SALESFORCE.COM, INC. | $107,574,790 | -4.0% | 530,500 | 0.0% | 7.95% | -8.2% | |
CORT | CORCEPT THERAPEUTICS INC | $92,044,178 | +22.5% | 3,377,768 | 0.0% | 6.80% | +17.1% | |
LANZATECH GLOBAL INC | $73,855,326 | -31.6% | 15,814,845 | 0.0% | 5.46% | -34.6% | ||
CABO | Buy | CABLE ONE INC | $72,893,623 | +17.9% | 118,403 | +25.8% | 5.39% | +12.7% |
TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $61,766,782 | -13.9% | 710,780 | 0.0% | 4.56% | -17.7% | |
DISC MEDICINE, INC. | $51,244,485 | +5.8% | 1,090,772 | 0.0% | 3.79% | +1.2% | ||
MIRM | Sell | MIRUM PHARMACEUTICALS INC | $47,400,000 | +8.8% | 1,500,000 | -10.9% | 3.50% | +4.0% |
BABA | ALIBABA GROUP HLDG LTDsponsored ads | $43,441,734 | +4.1% | 500,827 | 0.0% | 3.21% | -0.5% | |
PCVX | VAXCYTE INC | $43,078,100 | +2.1% | 845,000 | 0.0% | 3.18% | -2.4% | |
Buy | ARCELLX, INC. | $38,571,000 | +22.0% | 1,075,000 | +7.5% | 2.85% | +16.7% | |
AAPL | APPLE INC | $37,916,167 | -11.7% | 221,460 | 0.0% | 2.80% | -15.6% | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $35,392,000 | +2.1% | 400,000 | 0.0% | 2.62% | -2.4% | |
EWTX | EDGEWISE THERAPEUTICS INC | $34,790,858 | -26.1% | 6,071,703 | 0.0% | 2.57% | -29.3% | |
SGEN | SEAGEN INC. | $33,941,030 | +10.2% | 159,986 | 0.0% | 2.51% | +5.4% | |
INSM | INSMED INC | $33,817,426 | +19.7% | 1,339,304 | 0.0% | 2.50% | +14.4% | |
CRNX | CRINETICS PHARMACEUTICALS IN | $32,714,000 | +65.0% | 1,100,000 | 0.0% | 2.42% | +57.8% | |
PHVS | PHARVARIS N V | $27,743,013 | +37.8% | 1,329,325 | 0.0% | 2.05% | +31.8% | |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $26,365,500 | -7.0% | 525,000 | +17.0% | 1.95% | -11.1% |
FOLD | AMICUS THERAPEUTICS INC | $25,486,144 | -3.2% | 2,095,900 | 0.0% | 1.88% | -7.4% | |
RPHM | RENEO PHARMACEUTICALS INC | $25,344,169 | +16.0% | 3,330,377 | 0.0% | 1.87% | +11.0% | |
CBAY | Sell | CYMABAY THERAPEUTICS INC | $23,356,828 | +6.7% | 1,566,521 | -21.7% | 1.73% | +2.0% |
ALNY | ALNYLAM PHARMACEUTICALS INC | $20,965,629 | -6.8% | 118,383 | 0.0% | 1.55% | -10.8% | |
New | BROOKFIELD ASSET MANAGMT LTD | $20,911,081 | – | 627,207 | +100.0% | 1.54% | – | |
RCKT | Buy | ROCKET PHARMACEUTICALS INC | $20,510,490 | +12.2% | 1,001,000 | +8.8% | 1.52% | +7.3% |
FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $15,276,000 | -15.5% | 1,200,000 | +20.0% | 1.13% | -19.1% |
SPRB | SPRUCE BIOSCIENCES INC | $15,192,479 | +5.1% | 6,722,336 | 0.0% | 1.12% | +0.5% | |
INSP | Buy | INSPIRE MED SYS INC | $11,906,400 | +12.8% | 60,000 | +84.6% | 0.88% | +8.0% |
Buy | IO BIOTECH INC | $8,103,364 | +26.4% | 5,747,067 | +75.3% | 0.60% | +21.0% | |
RALLYBIO CORP | $7,373,557 | -40.5% | 2,187,999 | 0.0% | 0.54% | -43.1% | ||
ABCL | ABCELLERA BIOLOGICS INC | $5,183,809 | -28.8% | 1,126,915 | 0.0% | 0.38% | -32.0% | |
SILK | SILK RD MED INC | $5,004,921 | -53.9% | 333,884 | 0.0% | 0.37% | -55.8% | |
TMCI | TREACE MED CONCEPTS INC | $4,719,600 | -48.7% | 360,000 | 0.0% | 0.35% | -51.0% | |
LVTX | LAVA THERAPEUTICS NV | $3,528,000 | -27.6% | 2,400,000 | 0.0% | 0.26% | -30.6% | |
MQ | MARQETA INC | $2,640,517 | +22.8% | 441,558 | 0.0% | 0.20% | +17.5% | |
CYT | Sell | CYTEIR THERAPEUTICS INC | $1,920,916 | -79.8% | 676,379 | -81.5% | 0.14% | -80.7% |
GLTO | GALECTO INC | $1,798,410 | -71.4% | 2,497,791 | 0.0% | 0.13% | -72.6% | |
KNTE | KINNATE BIOPHARMA INC | $1,141,990 | -53.8% | 815,707 | 0.0% | 0.08% | -56.0% | |
SPRO | SPERO THERAPEUTICS INC | $567,371 | -16.6% | 468,902 | 0.0% | 0.04% | -20.8% | |
GRTX | Exit | GALERA THERAPEUTICS INC | $0 | – | -2,100,000 | -100.0% | -0.51% | – |
VERV | Exit | VERVE THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -0.72% | – |
BAM | Exit | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $0 | – | -627,207 | -100.0% | -1.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
INOGEN INC | 34 | Q2 2022 | 68.8% |
VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
CABLE ONE INC | 19 | Q3 2023 | 9.7% |
FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-25 |
SC 13D/A | 2024-03-25 |
4 | 2024-03-20 |
SC 13D/A | 2024-03-20 |
144 | 2024-03-18 |
4 | 2024-03-18 |
SC 13D/A | 2024-03-18 |
144 | 2024-03-14 |
SC 13D/A | 2024-03-07 |
4 | 2024-02-15 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.